PMID- 36996966 OWN - NLM STAT- MEDLINE DCOM- 20230501 LR - 20230501 IS - 1090-2430 (Electronic) IS - 0014-4886 (Linking) VI - 364 DP - 2023 Jun TI - Amphetamines abuse and depression: Focus on TRPC channels. PG - 114391 LID - S0014-4886(23)00075-4 [pii] LID - 10.1016/j.expneurol.2023.114391 [doi] AB - Amphetamines, such as amphetamine (AMPH), methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA), are the psychotropic substances widely abused in the world. Amphetamines abuse can damage dopaminergic and serotonin neurons and cause neuroinflammation and neurotoxicity. Neuropsychiatric disorders induced by amphetamines abuse include depression, anxiety, auditory hallucinations, mania, and cognitive disorders, of which depression has a higher incidence. Transient receptor potential (TRP) channels can regulate the inflow and outflow of Ca(2+). In TRP family, transient receptor potential canonical (TRPC) channels are closely associated with the development of some neurological diseases, such as Parkinson's disease and Alzheimer's disease. However, the correlation between TRPC channels and depression and the specific mechanism of TRPC channels in depression still haven't been fully clarified. This review elaborates the pathophysiological mechanisms of depression induced by amphetamines abuse, the functions of TRPC channels in the nervous system, and the possible correlation between TRPC channels and depression induced by amphetamines abuse, which would provide the theoretical basis for the development of the novel and effective therapeutic drugs for amphetamines abuse-induced depression. CI - Copyright (c) 2023 Elsevier Inc. All rights reserved. FAU - Fu, You-Peng AU - Fu YP AD - Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, China. FAU - Wang, Yun AU - Wang Y AD - Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, China. Electronic address: ywang28@cmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20230328 PL - United States TA - Exp Neurol JT - Experimental neurology JID - 0370712 RN - 0 (Transient Receptor Potential Channels) RN - 0 (Amphetamines) RN - 44RAL3456C (Methamphetamine) RN - 0 (Central Nervous System Stimulants) RN - CK833KGX7E (Amphetamine) SB - IM MH - *Transient Receptor Potential Channels MH - Depression/chemically induced MH - Amphetamines/adverse effects MH - *Methamphetamine MH - *Central Nervous System Stimulants/toxicity MH - Amphetamine OTO - NOTNLM OT - 3,4-methylenedioxymethamphetamine OT - Amphetamine OT - Depression OT - Methamphetamine OT - TRPC COIS- Declaration of Competing Interest The authors declare that there are no conflicts of interest. EDAT- 2023/03/31 06:00 MHDA- 2023/05/01 06:42 CRDT- 2023/03/30 19:25 PHST- 2022/12/07 00:00 [received] PHST- 2023/03/13 00:00 [revised] PHST- 2023/03/25 00:00 [accepted] PHST- 2023/05/01 06:42 [medline] PHST- 2023/03/31 06:00 [pubmed] PHST- 2023/03/30 19:25 [entrez] AID - S0014-4886(23)00075-4 [pii] AID - 10.1016/j.expneurol.2023.114391 [doi] PST - ppublish SO - Exp Neurol. 2023 Jun;364:114391. doi: 10.1016/j.expneurol.2023.114391. Epub 2023 Mar 28.